Do dreams tell the future? Dream content analysis as a predictor of cognitive deterioration in Parkinson’s Disease
Objective: Assess the predicitive value of dream content for cognitive dysfuncion progression in Parkinson's Disease (PD). Background: PD patients frequently complain of vivid dreams. Cross-sectional…Reduced Striatal VMAT2 in REM Sleep Behavior Disorder: A Gateway to Preclinical Parkinson’s Disease
Objective: To determine the degree of striatal degeneration that occurs in subjects with REM Sleep Behavior Disorder (RBD) and assess whether this is an appropriate…Impact of Chronotypes and melatonin levels on sleep disorders in patients with Parkinson’s disease
Objective: To investigate the sleep problems and circadian rhythm abnormalities in PD patients using sleep evaluation scale – Parkinsons disease sleep scale (PDSS) for mild…Autonomic symptoms as biomarkers in REM Sleep Behavior Disorder and Parkinson’s disease
Objective: This study was designed to evaluate autonomic functions in iRBD compared to PD and controls including longitudinal follow-up assessments to evaluate their potential to…Is Chronotype a biomarker for depression in military Veterans with Parkinson’s disease?
Objective: To determine the association of different chronotypes with depression in military Veterans with Parkinson's disease (PD). Background: Depression is a common non-motor symptom in…Relationship between REM sleep without atonia and sleep architecture in multiple system atrophy
Objective: To investigate whether REM sleep without atonia (RWA) is associated with sleep architecture in patients with multiple system atrophy (MSA). Background: In MSA patients,…Baseline hyposmia and RBD symptoms are associated with faster, but differential, cognitive decline at 2 years in the PPMI study
Objective: To explore the potential role of baseline hyposmia and RBD symptoms on progression of cognitive decline at 2 years. Background: Cognitive decline in PD…The effects of zonisamide on motor and non-motor symptoms in patients with Parkinson’s disease: a 3-month open-label study
Objective: To investigate the effect of zonisamide (ZNS) on motor and non-motor symptoms, such as depressive symptoms and sleep problems, in patients with Parkinson’s disease…Motor and non-motor symptoms related to sleep disturbances in Parkinson’s disease
Objective: To assess which (non-)motor symptoms are associated with the longitudinal development of sleep disturbances, one of the major non-motor symptoms (NMS) in Parkinson’s disease…Relationship between non-motor symptoms, medications and sleep interruptions in patients with Parkinson’s disease
Objective: To explore the relationship between sleep quality and medical treatment in patients with PD. Background: Disturbances, autonomic dysfunction and depression are common non-motor symptoms…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 11
- Next Page »